JP MORGAN/CALL/ELI LILLY & CO/810/0.01/20.09.24 Stock

Warrant

DE000JK2EY58

Real-time Bid/Ask 07:10:21 2024-07-05 am EDT
1.06 EUR / 1.07 EUR +4.41% Intraday chart for JP MORGAN/CALL/ELI LILLY & CO/810/0.01/20.09.24
Current month-14.29%
1 month+47.83%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-04 1.02 -12.07%
24-07-03 1.16 +10.48%
24-07-02 1.05 -8.70%
24-07-01 1.15 -3.36%
24-06-28 1.19 +5.31%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 04:45 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
Issuer J.P. Morgan
WKN JK2EY5
ISINDE000JK2EY58
Date issued 2024-02-08
Strike 810 $
Maturity 2024-09-20 (78 Days)
Parity 100 : 1
Emission price 0.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.19
Lowest since issue 0.29
Spread 0.01
Spread %0.93%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1 USD
Average target price
870.3 USD
Spread / Average Target
-3.10%
Consensus